BAM
TECH icon

Blueshift Asset Management’s Bio-Techne TECH Stock Holding History

Blueshift Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,285
Closed -$405K – 652
2025
Q3 		$405K Buy
+7,285
New +$390K 0.12% 240
2025
Q2 		– Sell
-14,860
Closed -$871K – 596
2025
Q1 		$871K Buy
+14,860
New +$1.01M 0.35% 74
2023
Q2 		– Sell
-3,630
Closed -$269K – 473
2023
Q1 		$269K Buy
+3,630
New +$280K 0.11% 243
2022
Q4 		– Sell
-4,896
Closed -$348K – 630
2022
Q3 		$348K Sell
4,896
-1,920
-28% -$166K 0.07% 366
2022
Q2 		$591K Buy
+6,816
New +$639K 0.1% 299

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Blueshift Asset Management's TECH Position: Q4 2025 in Review

Blueshift Asset Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 7,285 shares — an estimated $405K sold.

Blueshift Asset Management first reported a position in TECH in Q2 2022 and held it in 5 quarters. The position peaked at $871K in Q1 2025. 586 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Blueshift Asset Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 7,285 Bio-Techne shares in Q4 2025, an estimated $405K.
  • Blueshift Asset Management first reported a position in Bio-Techne in Q2 2022 and held it in 5 quarters.
  • Blueshift Asset Management's Bio-Techne position peaked at $871K in Q1 2025.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Blueshift Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.